Bayer Pharma Aktiengesellschaft

Bayer Schering Pharma Ag

Bayer Aktiengesellschaft

Astrazeneca Ab

Bayer Intellectual Property Gmbh

Heike Schäcke

Hartmut Rehwinkel

Markus Berger

Jorma Hassfeld

Thomas Zollner

Ulrich Klar

Rolf Bohlmann

Norbert Schmees

Stefan Jaroch

Detlev Sülzle

Olaf Panknin

Jan Dahmen

Stefan Bäurle

Ekkehard May

Stephan Menz

Bkkehard May

The present invention relates to substituted dihydroimidazopyridinedione compounds of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative, angiogenesis disorders, inflammatory diseases or diseases associated with inflammatory pain, as a sole agent or in combination with other active ingredients.

Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors

The present invention relates to compounds of formula I, processes for their production and their use as anti-inflammatory agents.

[object Object]

5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents

The present invention relates to the compounds of formula I, processes for their production and their use as anti-inflammatory agents.

Benzyl, amines, a process for their production and their use as anti-inflammatory agents

The invention relates to multiply substituted tetrahydronaphthalene derivatives of the formula (Ia) to processes for preparing them and to their use as antiinflammatory agents.

Tetrahydronaphthalene derivatives, methods for the production thereof, and the use thereof as antiphlogistics

Growing community of inventors

Berlin, Germany

Heike Schäcke